Two Sigma Securities’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-9,333
Closed -$750K 1604
2025
Q4
$750K Buy
+9,333
New +$781K 0.1% 258
2025
Q3
Sell
-3,295
Closed -$230K 1335
2025
Q2
$230K Buy
+3,295
New +$188K 0.03% 836
2024
Q1
Sell
-5,079
Closed -$605K 2892
2023
Q4
$659K Buy
5,079
+914
+22% +$126K 0.01% 1338
2023
Q3
$679K Buy
+4,165
New +$733K 0.01% 1296

Other funds holding ACLS

Two Sigma Securities's ACLS Position: Q1 2026 in Review

Two Sigma Securities sold out of Axcelis (ACLS) in Q1 2026, closing a stake of 9,333 shares — an estimated $750K sold.

Two Sigma Securities first reported a position in ACLS in Q3 2023 and held it in 4 quarters. The position peaked at $750K in Q4 2025. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.

  • Two Sigma Securities reported no remaining Axcelis position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Securities sold 9,333 Axcelis shares in Q1 2026, an estimated $750K.
  • Two Sigma Securities first reported a position in Axcelis in Q3 2023 and held it in 4 quarters.
  • Two Sigma Securities's Axcelis position peaked at $750K in Q4 2025.
  • 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.